AAAAAA

   
Results: 1-16 |
Results: 16
Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury
Authors: Ricciardi, R Schaffer, BK Shah, SA Quarfordt, SH Banner, BF Wheeler, SM Donohue, SE Meyers, WC Chari, RS
Citation: R. Ricciardi et al., Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury, J GASTRO S, 5(3), 2001, pp. 322-329
p53: A good diagnostic marker for intratubular germ cell neoplasia, unclassified
Authors: Moore, BE Banner, BF Gokden, M Woda, B Liu, Y Ayala, A Jiang, Z
Citation: Be. Moore et al., p53: A good diagnostic marker for intratubular germ cell neoplasia, unclassified, APPL IMMUNO, 9(3), 2001, pp. 203-206
Comparative effects of different doses of ribavirin plus interferon-alpha(2b) for therapy of chronic hepatitis C - Results of a controlled, randomized trial
Authors: Bonkovsky, HL Stefancyk, D McNeal, K Banner, BF Liu, Q Zucker, GM Israel, J Stagias, J Colker, J
Citation: Hl. Bonkovsky et al., Comparative effects of different doses of ribavirin plus interferon-alpha(2b) for therapy of chronic hepatitis C - Results of a controlled, randomized trial, DIG DIS SCI, 46(10), 2001, pp. 2051-2059
An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas
Authors: Zhao, J Liang, SX Savas, L Banner, BF
Citation: J. Zhao et al., An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas, ARCH PATH L, 125(6), 2001, pp. 765-769
Ubiquitin as a marker of cell Injury in nonalcoholic steatohepatitis
Authors: Banner, BF Savas, L Zivny, J Tortorelli, K Bonkovsky, HL
Citation: Bf. Banner et al., Ubiquitin as a marker of cell Injury in nonalcoholic steatohepatitis, AM J CLIN P, 114(6), 2000, pp. 860-866
Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
Authors: Fontana, RJ Israel, J LeClair, P Banner, BF Tortorelli, K Grace, N Levine, RA Fiarman, G Thiim, M Tavill, AS Bonkovsky, HL
Citation: Rj. Fontana et al., Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial, HEPATOLOGY, 31(3), 2000, pp. 730-736
Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder
Authors: Duval, JV Savas, L Banner, BF
Citation: Jv. Duval et al., Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder, ARCH PATH L, 124(8), 2000, pp. 1196-1200
Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease
Authors: Katsuta, T Lim, C Shimoda, K Shibuta, K Mitra, P Banner, BF Mori, M Barnard, GF
Citation: T. Katsuta et al., Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease, AM J GASTRO, 95(11), 2000, pp. 3157-3164
Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration
Authors: Kohlroser, J Mathai, J Reichheld, J Banner, BF Bonkovsky, HL
Citation: J. Kohlroser et al., Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration, AM J GASTRO, 95(1), 2000, pp. 272-276
IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy
Authors: Mathai, J Shimoda, K Banner, BF Mori, M Bonkovsky, HL Barnard, GF
Citation: J. Mathai et al., IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy, J INTERF CY, 19(9), 1999, pp. 1011-1018
CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver
Authors: Mitra, P Shibuta, K Mathai, J Shimoda, K Banner, BF Mori, M Barnard, GF
Citation: P. Mitra et al., CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver, INT J ONCOL, 14(5), 1999, pp. 917-925
Vascular endothelial growth factor vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
Authors: Shimoda, K Mori, M Shibuta, K Banner, BF Barnard, GF
Citation: K. Shimoda et al., Vascular endothelial growth factor vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma, INT J ONCOL, 14(2), 1999, pp. 353-359
Invariant chain expression in colon neoplasms
Authors: Jiang, Z Xu, MZ Savas, L LeClair, P Banner, BF
Citation: Z. Jiang et al., Invariant chain expression in colon neoplasms, VIRCHOWS AR, 435(1), 1999, pp. 32-36
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
Authors: Bonkovsky, HL Jawaid, Q Tortorelli, K LeClair, P Cobb, J Lambrecht, RW Banner, BF
Citation: Hl. Bonkovsky et al., Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis, J HEPATOL, 31(3), 1999, pp. 421-429
The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria
Authors: Reichheld, JH Katz, E Banner, BF Szymanski, IO Saltzman, JR Bonkovsky, HL
Citation: Jh. Reichheld et al., The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria, TRANSPLANT, 67(6), 1999, pp. 922-928
What is the normal aganglionic segment of anorectum in adults?
Authors: Ricciardi, R Counihan, TC Banner, BF Sweeney, WB
Citation: R. Ricciardi et al., What is the normal aganglionic segment of anorectum in adults?, DIS COL REC, 42(3), 1999, pp. 380-382
Risultati: 1-16 |